Study to Examine Pain Relief With Supplemental Intrathecal Morphine in TKA Patients
Status:
Unknown status
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
This is a prospective, randomized, double-blinded, placebo-controlled study designed to
examine pain relief following intrathecal morphine sulfate (0.2mg) in patients undergoing
total knee arthroplasty (TKA) under spinal anesthesia in addition to a femoral nerve
catheter. The protocol consists of two parts: (1) a prospective patient recruitment study and
(2) a retrospective assay for endocannabinoids on previously collected specimens.